Literature DB >> 19362964

Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.

Sigurdur Y Kristinsson1, Jill Koshiol, Lynn R Goldin, Magnus Björkholm, Ingemar Turesson, Gloria Gridley, Mary L McMaster, Ola Landgren.   

Abstract

There are emerging data to support a role for genetic and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. In this article, we review our recently published, large, population-based studies using data from Sweden and from United States veterans and propose mechanisms and pathways underlying our observations. We also discuss future directions for new studies designed to increase our current knowledge and to define underlying biologic mechanisms of our findings. Finally, based on novel insights on this topic, we discuss clinical implications and provide perspective on the relevance of these data for patient counseling and clinical follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19362964      PMCID: PMC2796606          DOI: 10.3816/CLM.2009.n.004

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  37 in total

Review 1.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

2.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

3.  Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia.

Authors:  J M Fine; P Lambin; M Massari; P Leroux
Journal:  Acta Med Scand       Date:  1982-05

4.  Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland.

Authors:  T Hakulinen; H Isomaki; P Knekt
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

5.  Familial aggregation of Hodgkin lymphoma and related tumors.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Gloria Gridley; Mitchell H Gail; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Kari Hemminki; Martha S Linet
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

6.  Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Ellen D Remstein; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

7.  Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.

Authors:  Stefan Hohaus; Giuseppina Massini; Francesco D'Alo'; Francesco Guidi; Rossana Putzulu; Alessandra Scardocci; Andras Rabi; Anna Laura Di Febo; Maria Teresa Voso; Giuseppe Leone
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

8.  Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.

Authors:  Roelandt F J Schop; W Michael Kuehl; Scott A Van Wier; Gregory J Ahmann; Tammy Price-Troska; Richard J Bailey; Syed M Jalal; Ying Qi; Robert A Kyle; Philip R Greipp; Rafael Fonseca
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

Review 9.  Waldenström macroglobulinaemia.

Authors:  Irene M Ghobrial; Morie A Gertz; Rafael Fonseca
Journal:  Lancet Oncol       Date:  2003-11       Impact factor: 41.316

10.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  3 in total

Review 1.  Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Ingemar Turesson; Magnus Björkholm; Ola Landgren
Journal:  Acta Haematol       Date:  2012-02-03       Impact factor: 2.195

2.  Blood transfusions and the subsequent risk of hematologic malignancies.

Authors:  Cindy M Chang; Scott C Quinlan; Joan L Warren; Eric A Engels
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

Review 3.  How to manage Waldenstrom's macroglobulinemia.

Authors:  C Buske; V Leblond
Journal:  Leukemia       Date:  2013-02-06       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.